To further support the notion that it is the mislocalization of NPM1 in the AML cells that causes the polη deficiency, we treated the cells with Leptomycin B, an inhibitor of nuclear export via exportin 1, previously shown to prevent the exclusion of NPM1 from the nucleus46. The gene discussed is XPO1; the disease is acute myeloid leukemia.